Linked Life Data

1698143

Source:http://linkedlifedata.com/resource/pubmed/id/1698143

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1698143rdf:typepubmed:Citationlld:pubmed
pubmed-article:1698143lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C0030011lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C1158366lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C1256369lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C1522240lld:lifeskim
pubmed-article:1698143lifeskim:mentionsumls-concept:C1948027lld:lifeskim
pubmed-article:1698143pubmed:issue4lld:pubmed
pubmed-article:1698143pubmed:dateCreated1990-10-22lld:pubmed
pubmed-article:1698143pubmed:abstractTextShort- and long-term effects of hyperlipidemia with elevated FFA on insulin secretion were investigated. Male Sprague-Dawley rats were fed ad libitum and additionally infused with Intralipid 10%, 1.0 ml/h. After 3 h of Intralipid the response to 27 mM glucose in isolated perfused pancreas was enhanced by 86%, P less than 0.02. After 6 h of Intralipid enhancement had subsided. After 48 h of Intralipid glucose-induced insulin release was inhibited by 49%, from 1950 +/- 177 microU/min after saline to 1003 +/- 232 microU/min after Intralipid, P less than 0.02. Inhibition was glucose-selective since responses to other secretagogues (1 mM 3-isobutyl-1 methylxanthine, 10 mM octanoate, or 5 mM alpha-ketoisocaproic acid) were unaffected as were pancreatic contents of insulin (2284 +/- 111 mU/pancreas after saline, 2566 +/- 131 mU/pancreas after Intralipid). In isolated islets from 48 h lipid infused rats production of [14-C]CO2 from D[U-14-C]glucose was decreased (P less than 0.02) in parallel with the insulin response to 27 mM glucose. Glucose-induced secretion was partially normalized by in vitro exposure to a carnitine palmitoyl-transferase I inhibitor (Etomoxir). Effects of a 48 h lipid infusion were also tested during hyperglycemia. Rats were infused with glucose, and hyperglycemia was enhanced by dexamethasone (25 micrograms/24 h). Hyperglycemia depressed glucose-induced secretion from perfused pancreas from 2072 +/- 22 microU/min after saline + dexamethasone to 1185 +/- 155 microU/min after glucose + dexamethasone, P less than 0.01). Intralipid, added to the latter protocol, further inhibited glucose-induced secretion to 437 +/- 87 microU/min, P less than 0.005. Hyperlipidemia is concluded to be associated with short term stimulation but long term inhibition of glucose-induced insulin secretion. Evidence indicates that inhibition depends on fatty acid oxidation, is coupled to decreased glucose oxidation and operates both during normo- and hyperglycemia.lld:pubmed
pubmed-article:1698143pubmed:languageenglld:pubmed
pubmed-article:1698143pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1698143pubmed:statusMEDLINElld:pubmed
pubmed-article:1698143pubmed:monthOctlld:pubmed
pubmed-article:1698143pubmed:issn0013-7227lld:pubmed
pubmed-article:1698143pubmed:authorpubmed-author:SakoYYlld:pubmed
pubmed-article:1698143pubmed:authorpubmed-author:GrillV EVElld:pubmed
pubmed-article:1698143pubmed:issnTypePrintlld:pubmed
pubmed-article:1698143pubmed:volume127lld:pubmed
pubmed-article:1698143pubmed:ownerNLMlld:pubmed
pubmed-article:1698143pubmed:authorsCompleteYlld:pubmed
pubmed-article:1698143pubmed:pagination1580-9lld:pubmed
pubmed-article:1698143pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:meshHeadingpubmed-meshheading:1698143-...lld:pubmed
pubmed-article:1698143pubmed:year1990lld:pubmed
pubmed-article:1698143pubmed:articleTitleA 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation.lld:pubmed
pubmed-article:1698143pubmed:affiliationDepartment of Endocrinology, Karolinska Hospital, Stockholm, Sweden.lld:pubmed
pubmed-article:1698143pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1698143pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1698143lld:pubmed